| Scientific Name |
Trastuzumab
|
|---|---|
| Brand Name |
Herceptin
|
| Risk |
Reminder of importance of cardiac monitoring guidance during trastuzumab therapy to reduce the frequency and severity of left ventricular dysfunction and congestive heart failure.
|
| Dear Healthcare Professional Communication (DHPC) for Healthcare Professionals |
|
| Safety Communication for Healthcare Professionals |
|